Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity

Rheumatology (United Kingdom)

Volumn 53, Issue 7, 2014, Pages 1307-1312

  Ciccia, Francesco ^a   Rizzo, Aroldo ^a   Alessandro, Riccardo ^a   Guggino, Giuliana ^a   Maugeri, Rosario ^a   Saieva, Laura ^a   Cannizzaro, Alessandra ^a   Giardina, AnnaRita ^a   De Leo, Giacomo ^a   Iacopino, Domenico Gerardo ^a   Triolo, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Dermatomyositis; IL 17; IL 22; IL 22R1; P STAT3; Polymyositis

Indexed keywords

BINDING PROTEIN; CYTOKINE RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 22 BINDING PROTEIN; INTERLEUKIN 22 RECEPTOR 1; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY INFILTRATE; MONONUCLEAR CELL; MUSCLE CELL; MUSCLE NECROSIS; MUSCLE TISSUE; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

DERMATOMYOSITIS; IL-17; IL-22; IL-22R1; P-STAT3; POLYMYOSITIS;

BIOPSY; CASE-CONTROL STUDIES; DERMATOMYOSITIS; HUMANS; INFLAMMATION; INTERLEUKINS; MUSCLE, SKELETAL; NECROSIS; POLYMYOSITIS; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84902958553     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu005     Document Type: Article

References (14)

1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.
2. Tournadre A, Lenief V, Miossec P. Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum 2010;62:2144-51.
3. Chevrel G, Page G, Granet C et al. Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol 2003;137:125-33.
4. Ciccia F, Guggino G, Rizzo A et al. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. Ann Rheum Dis 2012;71:295-301.
5. Ikeuchi H, Kuroiwa T, Hiramatsu N et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 2005;52: 1037-46.
6. Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev 2013;252:116-32.
7. Bohan A, Peter JB, Bowman RL et al. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977;56:255-86.
8. Rider LG, Werth VP, Huber AM et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res 2011;63(Suppl 11):S118-57.
9. Volpe E, Touzot M, Servant N et al. Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood 2009;114:3610-4.
10. Volpe E, Servant N, Zollinger R et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008;9:650-7.
11. Chang Y, Al-Alwan L, Risse PA et al. TH17 cytokines induce human airway smooth muscle cell migration. J Allergy Clin Immunol 2011;127:1046-53.e1-2.
12. Bhatnagar S, Panguluri SK, Gupta SK et al. Tumor necrosis factor-a regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLoS One 2010;5:e13262.
13. Englund P, Nennesmo I, Klareskog L, Lundberg IE. Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum 2002;46:1044-55.
14. Kebir H, Kreymborg K, Ifergan I et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007;13: 1173-5.